| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0009 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |